Ignite Creation Date:
2024-05-06 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 2:29 PM
Study NCT ID:
NCT05310123
Status:
UNKNOWN
Last Update Posted:
2022-04-11
First Post:
2022-03-02
Brief Title:
AC-11 Supplement and Biological Aging
Sponsor:
TruDiagnostic
Organization:
TruDiagnostic
Study Overview
Official Title:
Investigation of AC-11 Supplementation in Reversing Epigenetic Markers of Biological Aging Including Those Related to Telomere Length
Status:
UNKNOWN
Status Verified Date:
2022-04
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective non-randomized clinical study of 24 patients to evaluate the effects of the AC-11 The study will evaluate the effectiveness of the supplements ability to reverse epigenetic markers of biological age The duration of the study will be 6 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None